B-Secur

About:

Experts in ECG Technology- from electrode design to Algorithms. We are on a mission to enable Medical- Grade ECG Everywhere.

Website: http://www.b-secur.com/

Twitter/X: @bsecurtech/

Top Investors: Upscale, ADV, Kernel Capital, Clarendon Fund Managers, Wharton Asset Management Company Limited

Description:

B-Secur are on a mission to revolutionise the way people experience technology in the connected world using their unique heartbeat. We’ve invested over 15 years of deep, scientific research in ECG to become a world leader in the development and integration of ECG technology, partnering with some of the world's leading technology companies. We’ve harnessed the power of ECG to create HeartKey®, offering advanced physiological monitoring with intrinsic data protection. We have developed a suite of powerful ECG algorithms and analytics for user identification, wellness, and health, ready for integration into leading devices and systems. B-Secur also have a combined 50+ years of in-house hardware and material science, which our partners can use to significantly reduce development costs on hardware and ECG electrode design. B-Secur and HeartKey® bring you our world class expertise in ECG combined with powerful, flexible integration and configuration possibilities to create your optimal product, with a competitive edge.

Total Funding Amount:

20.3M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Belfast, Belfast, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)b-secur.com

Founders:

Colin Anderson

Number of Employees:

51-100

Last Funding Date:

2023-07-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai